Dutch CPE surveillance Study Group, van der Zwaluw, K., Witteveen, S., Wielders, L., van Santen, M., Landman, F., de Haan, A., Schouls, L. M., & Bosch, T. (2020). Molecular characteristics of carbapenemase-producing Enterobacterales in the Netherlands; results of the 2014-2018 national laboratory surveillance. Clinical Microbiology and Infection, 26(10), 1412.e7-1412.e12. https://doi.org/10.1016/j.cmi.2020.01.027

Lederhofer, J., van Lent, J., Bhoelan, F., Karneva, Z., de Haan, A., Wilschut, J. C., & Stegmann, T. (2018). Development of a Virosomal RSV Vaccine Containing 3D-PHADA (R) Adjuvant: Formulation, Composition, and Long-Term Stability. Pharmaceutical Research, 35(9), [172]. https://doi.org/10.1007/s11095-018-2453-y

Dong, W., Bhide, Y., Marsman, S., Holtrop, M., Meijerhof, T., de Vries-Idema, J., de Haan, A., & Huckriede, A. (2018). Monophosphoryl Lipid A-Adjuvanted Virosomes with Ni-Chelating Lipids for Attachment of Conserved Viral Proteins as Cross-Protective Influenza Vaccine. Biotechnology Journal, 13(4), [1700645]. https://doi.org/10.1002/biot.201700645

Patil, H. P., Murugappan, S., de Vries-Idema, J., Meijerhof, T., de Haan, A., Frijlink, H. W., Wilschut, J., Hinrichs, W. L. J., & Huckriede, A. (2015). Comparison of adjuvants for a spray freeze-dried whole inactivated virus influenza vaccine for pulmonary administration. European Journal of Pharmaceutics and Biopharmaceutics, 93, 231-241. https://doi.org/10.1016/j.ejpb.2015.04.004

Tete, S. M., Kipling, D., Westra, J., de Haan, A., Bijl, M., Dunn-Walters, D. K., Sahota, S. S., & Bos, N. A. (2015). Monoclonal paraprotein influences baseline B-cell repertoire diversity and perturbates influenza vaccination-induced B-cell response. Experimental Hematology, 43(6), 439-447. https://doi.org/10.1016/j.exphem.2015.02.005

Rondaan, C., de Haan, A., Horst, G., Hempel, J. C., van Leer, C., Bos, N. A., van Assen, S., Bijl, M., & Westra, J. (2014). Altered cellular and humoral immunity to varicella-zoster virus in patients with autoimmune diseases. Arthritis & Rheumatology, 66(11), 3122-3128. https://doi.org/10.1002/art.38804

Westra, J., van Assen, S., Wilting, K. R., Land, J., Horst, G., de Haan, A., & Bijl, M. (2014). Rituximab impairs immunoglobulin (Ig)M and IgG (subclass) responses after influenza vaccination in rheumatoid arthritis patients. Clinical and Experimental Immunology, 178(1), 40-47. https://doi.org/10.1111/cei.12390

Keijzer, C., Haijema, B. J., Meijerhof, T., Voorn, P., de Haan, A., Leenhouts, K., van Roosmalen, M. L., van Eden, W., & Broere, F. (2014). Inactivated influenza vaccine adjuvanted with Bacterium-like particles induce systemic and mucosal influenza A virus specific T-cell and B-cell responses after nasal administration in a TLR2 dependent fashion. Vaccine, 32(24), 2904-2910. https://doi.org/10.1016/j.vaccine.2014.02.019

Patil, H. P., Murugappan, S., Ter Veer, W., Meijerhof, T., De Haan, A., Frijlink, H. W., Wilschut, J., Hinrichs, W. L. J., & Huckriede, A. (2014). Evaluation of monophosphoryl lipid A as adjuvant for pulmonary delivered influenza vaccine. Journal of controlled release : official journal of the Controlled Release Society, 174(1), 51-62. https://doi.org/10.1016/j.jconrel.2013.11.013

Smelt, M. J., Faas, M. M., de Haan, B. J., de Haan, A., Vaage, J. T., & de Vos, P. (2014). The role of alloresponsive Ly49⁺ NK cells in rat islet allograft failure in the presence and absence of cytomegalovirus. Cell Transplantation, 23(11), 1381-1394. https://doi.org/10.3727/096368913X670930

Kamphuis, T., Stegmann, T., Meijerhof, T., Wilschut, J., & de Haan, A. (2013). A virosomal respiratory syncytial virus vaccine adjuvanted with monophosphoryl lipid A provides protection against viral challenge without priming for enhanced disease in cotton rats. Influenza and other respiratory viruses, 7(6), 1227-1236. https://doi.org/10.1111/irv.12112

Wezenberg, D., van der Woude, L. H., Faber, W. X., de Haan, A., & Houdijk, H. (2013). Relation Between Aerobic Capacity and Walking Ability in Older Adults With a Lower-Limb Amputation. Archives of Physical Medicine and Rehabilitation, 94(9), 1714-1720. https://doi.org/10.1016/j.apmr.2013.02.016

Budimir, N., de Haan, A., Meijerhof, T., Waijer, S., Boon, L., Gostick, E., Price, D. A., Wilschut, J., & Huckriede, A. (2013). Critical Role of TLR7 Signaling in the Priming of Cross-Protective Cytotoxic T Lymphocyte Responses by a Whole Inactivated Influenza Virus Vaccine. PLoS ONE, 8(5), [e63163]. https://doi.org/10.1371/journal.pone.0063163

Kamphuis, T., Shafique, M., Meijerhof, T., Stegmann, T., Wilschut, J., & de Haan, A. (2013). Efficacy and safety of an intranasal virosomal respiratory syncytial virus vaccine adjuvanted with monophosphoryl lipid A in mice and cotton rats. Vaccine, 31(17), 2169-2176. https://doi.org/10.1016/j.vaccine.2013.02.043

Shafique, M., Meijerhof, T., Wilschut, J., & de Haan, A. (2013). Evaluation of an Intranasal Virosomal Vaccine against Respiratory Syncytial Virus in Mice: Effect of TLR2 and NOD2 Ligands on Induction of Systemic and Mucosal Immune Responses. PLoS ONE, 8(4), [e61287]. https://doi.org/10.1371/journal.pone.0061287

Wezenberg, D., de Haan, A., Faber, W. X., Slootman, H. J., van der Woude, L. H., & Houdijk, H. (2012). Peak Oxygen Consumption in Older Adults With a Lower Limb Amputation. Archives of Physical Medicine and Rehabilitation, 93(11), 1924-1929. https://doi.org/10.1016/j.apmr.2012.05.020

Geeraedts, F., ter Veer, W., Wilschut, J., Huckriede, A., & de Haan, A. (2012). Effect of viral membrane fusion activity on antibody induction by influenza H5N1 whole inactivated virus vaccine. Vaccine, 30(45), 6501-6507. https://doi.org/10.1016/j.vaccine.2012.07.036

de Haan, A., Haijema, B. J., Voorn, P., Meijerhof, T., van Roosmalen, M. L., & Leenhouts, K. (2012). Bacterium-like particles supplemented with inactivated influenza antigen induce cross-protective influenza-specific antibody responses through intranasal administration. Vaccine, 30(32), 4884-4891. https://doi.org/10.1016/j.vaccine.2012.04.032

Kamphuis, T., Meijerhof, T., Stegmann, T., Lederhofer, J., Wilschut, J., & de Haan, A. (2012). Immunogenicity and Protective Capacity of a Virosomal Respiratory Syncytial Virus Vaccine Adjuvanted with Monophosphoryl Lipid A in Mice. PLoS ONE, 7(5), [e36812]. https://doi.org/10.1371/journal.pone.0036812

Wezenberg, D., de Haan, A., van der Woude, L. H., & Houdijk, H. (2012). Feasibility and Validity of a Graded One-Legged Cycle Exercise Test to Determine Peak Aerobic Capacity in Older People With a Lower-Limb Amputation. Physical Therapy, 92(2), 329-338. https://doi.org/10.2522/ptj.20110125

Budimir, N., Huckriede, A., Meijerhof, T., Boon, L., Gostick, E., Price, D. A., Wilschut, J., & de Haan, A. (2012). Induction of Heterosubtypic Cross-Protection against Influenza by a Whole Inactivated Virus Vaccine: The Role of Viral Membrane Fusion Activity. PLoS ONE, 7(1), [e30898]. https://doi.org/10.1371/journal.pone.0030898

Shafique, M., Wilschut, J., & de Haan, A. (2012). Induction of mucosal and systemic immunity against respiratory syncytial virus by inactivated virus supplemented with TLR9 and NOD2 ligands. Vaccine, 30(3), 597-606. https://doi.org/10.1016/j.vaccine.2011.11.054

Jamali, A., Holtrop, M., de Haan, A., Hashemi, H., Shenagari, M., Memarnejadian, A., Roohvand, F., Sabahi, F., Kheiri, M. T., & Huckriede, A. (2012). Cationic influenza virosomes as an adjuvanted delivery system for CTL induction by DNA vaccination. Immunology Letters, 148(1), 77-82. https://doi.org/10.1016/j.imlet.2012.08.006

Van Assen, S., de Haan, A., Holvast, A., Horst, G., Gorter, L., Westra, J., Kallenberg, C. G. M., Telgt, D. S. C., Palache, A. M., Giezeman, K. M., & Bijl, M. (2011). Cell-mediated immune responses to inactivated trivalent influenza-vaccination are decreased in patients with common variable immunodeficiency. Clinical Immunology, 141(2), 161-168. https://doi.org/10.1016/j.clim.2011.07.004

Wezenberg, D., de Haan, A., van Bennekom, C. A. M., & Houdijk, H. (2011). Mind your step: Metabolic energy cost while walking an enforced gait pattern. Gait & Posture, 33(4), 544-549. https://doi.org/10.1016/j.gaitpost.2011.01.007

Smelt, M. J., Faas, M. M., Melgert, B. N., de Vos, P., de Haan, B., & de Haan, A. (2011). Effects of Acute Cytomegalovirus Infection on Rat Islet Allograft Survival. Cell Transplantation, 20(8), 1271-1283. https://doi.org/10.3727/096368910X545077

Budimir, N., Meijerhof, T., Wilschut, J., Huckriede, A., & de Haan, A. (2010). The role of membrane fusion activity of a whole inactivated influenza virus vaccine in (re)activation of influenza-specific cytotoxic T lymphocytes. Vaccine, 28(52), 8280-8287. https://doi.org/10.1016/j.vaccine.2010.10.007

Stegmann, T., Kamphuis, T., Meijerhof, T., Goud, E., de Haan, A., & Wilschut, J. (2010). Lipopeptide-adjuvanted respiratory syncytial virus virosomes: A safe and immunogenic non-replicating vaccine formulation. Vaccine, 28(34), 5543-5550. https://doi.org/10.1016/j.vaccine.2010.06.041

van Assen, S., Holvast, A., Telgt, D. S. C., Benne, C. A., de Haan, A., Westra, J., Kallenberg, C., & Bijl, M. (2010). Patients with humoral primary immunodeficiency do not develop protective anti-influenza antibody titers after vaccination with trivalent subunit influenza vaccine. Clinical Immunology, 136(2), 228-235. https://doi.org/10.1016/j.clim.2010.03.430

Holvast, A., de Haan, A., van Assen, S., Stegeman, C. A., Huitema, M. G., Huckriede, A., Benne, C. A., Westra, J., Palache, A., Wilschut, J., Kallenberg, C. G. M., & Bijl, M. (2010). Cell-mediated immune responses to influenza vaccination in Wegener's granulomatosis. Annals of the Rheumatic Diseases, 69(5), 924-927. https://doi.org/10.1136/ard.2009.112813

Van Assen, S., Holvast, A., Benne, C. A., Posthumus, M. D., Van Leeuwen, M. A., Voskuyl, A. E., Blom, M., Risselada, A. P., De Haan, A., Westra, J., Kallenberg, C., & Bijl, M. (2010). Humoral responses after influenza vaccination are severely reduced in patients with rheumatoid arthritis treated with rituximab. ARTHRITIS AND RHEUMATISM, 62(1), 75-81. https://doi.org/10.1002/art.25033

Smelt, M. J., Faas, M. M., de Haan, B. J., Hofstede, J., Cheung, C-W., van der Iest, H., de Haan, A., & de Vos, P. (2010). Rat Pancreatic beta Cells and Cytomegalovirus Infection. PANCREAS, 39(1), 47-56. https://doi.org/10.1097/MPA.0b013e3181bab120

Granic, I., Masman, M. F., Mulder, C. K., Nijholt, I. M., Naude, P. J. W., de Haan, A., Borbely, E., Penke, B., Luiten, P. G. M., & Eisel, U. L. M. (2010). LPYFDa Neutralizes Amyloid-beta-Induced Memory Impairment and Toxicity. Journal of alzheimers disease, 19(3), 991-1005. https://doi.org/10.3233/JAD-2010-1297

Holvast, A., van Assen, S., de Haan, A., Huckriede, A., Benne, C. A., Westra, J., Palache, A., Wilschut, J., Kallenberg, C., & Bijl, M. (2009). Effect of a second, booster, influenza vaccination on antibody responses in quiescent systemic lupus erythematosus: An open, prospective, controlled study. Rheumatology, 48(10), 1294-1299. https://doi.org/10.1093/rheumatology/kep200

Holvast, A., Van Assen, S., De Haan, A., Huckriede, A., Benne, C. A., Westra, J., Palache, A., Wilschut, J., Kallenberg, C., & Bijl, M. (2009). Studies of cell-mediated immune responses to influenza vaccination in systemic lupus erythematosus. ARTHRITIS AND RHEUMATISM, 60(8), 2438-2447. https://doi.org/10.1002/art.24679

Geeraedts, F., Goutagny, N., Hornung, V., Severa, M., de Haan, A., Pool, J., Wilschut, J., Fitzgerald, K. A., & Huckriede, A. (2008). Superior immunogenicity of inactivated whole virus H5N1 influenza vaccine is primarily controlled by Toll-like receptor signalling. PLoS Pathogens, 4(8), [1000138]. https://doi.org/10.1371/journal.ppat.1000138

Huijsmans, R. J., de Haan, A., ten Hacken, N. N. H. T., Straver, R. V. M., & van't Hu, A. J. (2008). The clinical utility of the GOLD classification of COPD disease severity in pulmonary rehabilitation. Respiratory Medicine, 102(1), 162-171. https://doi.org/10.1016/j.rmed.2007.07.008

Koopmans, J., de Haan, A., Bruin -van Dijk, E., van der Gun, I., Van Dijk, H., Rozing, J., de Leij, L., & Staal, M. (2006). Porcine fetal ventral mesencephalic cells are targets for primed xenoreactive human T cells. Cell Transplantation, 15(5), 381-387. https://doi.org/10.3727/000000006783981846

Boomker, JM., Luttikhuizen, DT., Veninga, H., de Leij, LFMH., The, TH., de Haan, A., van Luyn, MJA., & Harmsen, MC. (2005). The modulation of angiogenesis in the foreign body response by the poxviral protein M-T7. Biomaterials, 26(23), 4874-4881. https://doi.org/10.1016/j.biomaterials.2004.11.059

Qu, N., de Vos, P., Schelfhorst, M., de Haan, A., Timens, W., & Prop, J. (2005). Integrity of airway epithelium is essential against obliterative airway disease in transplanted rat tracheas. Journal of Heart and Lung Transplantation, 24(7), 882-890. https://doi.org/10.1016/j.healun.2004.04.020

Zweers, N., Petersen, AH., van der Hoeven, JAB., de Haan, A., Ploeg, RJ., de Leij, LFMH., & Prop, J. (2004). Donor brain death aggravates chronic rejection after lung transplantation in rats. Transplantation, 78(9), 1251-1258. https://doi.org/10.1097/01.TP.0000142679.45418.96

Koopmans, J., de Haan, A., Bruin, E., van der Gun, I., van Dijk, H., Rozing, J., de Leij, L., & Staal, M. (2004). Individual human serum differs in the amount of antibodies with affinity for pig fetal ventral mesencephalic cells and the ability to lyse these cells by complement activation. Cell Transplantation, 13(6), 631-637. https://doi.org/10.3727/000000004783983503

Faas, MM., Spijker, H., van Willigen, JW., de Vos, P., de Haan, B., & de Haan, A. (2004). Factors influencing isolation of functional pancreatic rat islets. PANCREAS, 29(1), E15-E22.

Scheenstra, R., Verschuuren, E. A. M., de Haan, A., Slooff, M. J. H., The, T. H., Bijleveld, C. M. A., & Verkade, H. J. (2004). The value of prospective monitoring of Epstein-Barr virus DNA in blood samples of pediatric liver transplant recipients. Transplant Infectious Disease, 6(1), 15-22. https://doi.org/10.1111/j.1399-3062.2004.00044.x

de Vos, P., de Haan, B. J., de Haan, A., van Zanten, J., & Faas, M. M. (2004). Factors influencing functional survival of microencapsulated islet grafts. Cell Transplantation, 13(5), 515-524. https://doi.org/10.3727/000000004783983738

Qu, N., de Haan, A., Harmsen, MC., Kroese, FGM., de Leij, LFMH., & Prop, J. (2003). Specific immune responses against airway epithelial cells in a transgenic mouse-trachea transplantation model for obliterative airway disease. Transplantation, 76(7), 1022-1028. https://doi.org/10.1097/01.TP.0000080607.28324.A9

de Vos, P., Smedema, I., van Goor, H., Moes, H., van Zanten, J., Netters, S., de Leij, LFM., de Haan, B., & de Haan, A. (2003). Association between macrophage activation and function of micro-encapsulated rat islets. Diabetologia, 46(5), 666-673. https://doi.org/10.1007/s00125-003-1087-7

de Haan, A., van der Gun, N. V., van der Bij, W., de Leij, LFMH., & Prop, J. (2002). Detection of alloreactive T cells by flow cytometry: A new test compared with limiting dilution assay. Transplantation, 74(4), 562-570. [UNSP 0041-1337/02/7404-562/0].

de Haan, A., van den Berg, AP., van der Bij, W., Hepkema, BG., Bruin-van Dijk, E., van der Gun, N. V., Lems, SPM., Slooff, MJH., Haagsma, EB., de Leij, LFMH., & Prop, J. (2001). Rapid decreases in donor-specific cytotoxic T lymphocyte precursor frequencies and graft outcome after liver and lung transplantation. Transplantation, 71(6), 785-791.

de Haan, A., van der Gun, N. V., van Dijk, E., Hepkema, BG., Prop, J., & de Leij, LFMH. (2000). Activation of alloreactive T cells by allogeneic nonprofessional antigenpresenting cells and interleukin-12 from bystander autologous professional antigenpresenting cells. Transplantation, 69(8), 1637-1644.